Literature DB >> 23752823

Helicobacter pylori research: historical insights and future directions.

Kwong Ming Fock1, David Y Graham, Peter Malfertheiner.   

Abstract

Helicobacter pylori leads to chronic gastritis, peptic ulcer disease and gastric cancer. With increasing issues of antibiotic resistance and changing epidemiology of this pathogen, new approaches are needed for effective management. In 1984, Dr Barry Marshall and Dr Robin Warren reported the association of Helicobacter pylori with peptic ulcers in The Lancet--a discovery that earned them the Nobel prize in Physiology or Medicine in 2005--but what progress have we made since then? Here, we have invited three international experts to give their insights into the advances in H. pylori research over the past 30 years and where research should be focused in the future.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23752823      PMCID: PMC3973742          DOI: 10.1038/nrgastro.2013.96

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


  45 in total

Review 1.  Eradication therapy for Helicobacter pylori.

Authors:  Nimish Vakil; Francis Megraud
Journal:  Gastroenterology       Date:  2007-09       Impact factor: 22.682

2.  Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection.

Authors:  K Ming Fock; Peter Katelaris; Kentaro Sugano; Tiing Leong Ang; Richard Hunt; Nicholas J Talley; Shiu Kum Lam; Shu-Dong Xiao; Huck Joo Tan; Chun-Ying Wu; Hyun Chae Jung; Bui Huu Hoang; Udom Kachintorn; Khean-Lee Goh; Tsutomu Chiba; Abdul Aziz Rani
Journal:  J Gastroenterol Hepatol       Date:  2009-10       Impact factor: 4.029

Review 3.  Development of vaccines against Helicobacter pylori.

Authors:  Giuseppe Del Giudice; Peter Malfertheiner; Rino Rappuoli
Journal:  Expert Rev Vaccines       Date:  2009-08       Impact factor: 5.217

Review 4.  Helicobacter pylori and gastric carcinogenesis.

Authors:  Masanori Hatakeyama
Journal:  J Gastroenterol       Date:  2009-03-07       Impact factor: 7.527

Review 5.  Basic aspects of gastric cancer.

Authors:  Marta Correia; José Carlos Machado; Ari Ristimäki
Journal:  Helicobacter       Date:  2009-09       Impact factor: 5.753

6.  Safety and immunogenicity of an intramuscular Helicobacter pylori vaccine in noninfected volunteers: a phase I study.

Authors:  Peter Malfertheiner; Viola Schultze; Bernd Rosenkranz; Stefan H E Kaufmann; Timo Ulrichs; Deborah Novicki; Francesco Norelli; Mario Contorni; Samuele Peppoloni; Duccio Berti; Daniela Tornese; Jitendra Ganju; Emanuela Palla; Rino Rappuoli; Bruce F Scharschmidt; Giuseppe Del Giudice
Journal:  Gastroenterology       Date:  2008-05-28       Impact factor: 22.682

7.  Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyond.

Authors:  David Y Graham; Hong Lu; Yoshio Yamaoka
Journal:  Drugs       Date:  2008       Impact factor: 9.546

8.  Changing antimicrobial susceptibility epidemiology of Helicobacter pylori strains in Japan between 2002 and 2005.

Authors:  Intetsu Kobayashi; Kazunari Murakami; Mototsugu Kato; Seiichi Kato; Takeshi Azuma; Shin'ichi Takahashi; Naomi Uemura; Tsutomu Katsuyama; Yoshihiro Fukuda; Ken Haruma; Masaru Nasu; Toshio Fujioka
Journal:  J Clin Microbiol       Date:  2007-10-17       Impact factor: 5.948

9.  Asia-Pacific consensus guidelines on gastric cancer prevention.

Authors:  Kwong Ming Fock; Nick Talley; Paul Moayyedi; Richard Hunt; Takeshi Azuma; Kentaro Sugano; Shu Dong Xiao; Shiu Kum Lam; Khean Lee Goh; Tsutomu Chiba; Naomi Uemura; Jae G Kim; Nayoung Kim; Tiing Leong Ang; Varocha Mahachai; Hazel Mitchell; Abdul Aziz Rani; Jyh Ming Liou; Ratha-Korn Vilaichone; Jose Sollano
Journal:  J Gastroenterol Hepatol       Date:  2008-03       Impact factor: 4.029

10.  Correlation of T cell response and bacterial clearance in human volunteers challenged with Helicobacter pylori revealed by randomised controlled vaccination with Ty21a-based Salmonella vaccines.

Authors:  T Aebischer; D Bumann; H J Epple; W Metzger; T Schneider; G Cherepnev; A K Walduck; D Kunkel; V Moos; C Loddenkemper; I Jiadze; M Panasyuk; M Stolte; D Y Graham; M Zeitz; T F Meyer
Journal:  Gut       Date:  2008-04-16       Impact factor: 23.059

View more
  37 in total

Review 1.  Survival of Helicobacter pylori in gastric acidic territory.

Authors:  Shamshul Ansari; Yoshio Yamaoka
Journal:  Helicobacter       Date:  2017-04-12       Impact factor: 5.753

2.  In Vitro and In Vivo Activities of Zinc Linolenate, a Selective Antibacterial Agent against Helicobacter pylori.

Authors:  Yanqiang Huang; Xudong Hang; Xueqing Jiang; Liping Zeng; Jia Jia; Yong Xie; Fei Li; Hongkai Bi
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

3.  Selective killing of Helicobacter pylori with pH-responsive helix-coil conformation transitionable antimicrobial polypeptides.

Authors:  Menghua Xiong; Yan Bao; Xin Xu; Hua Wang; Zhiyuan Han; Zhiyu Wang; Yeqing Liu; Songyin Huang; Ziyuan Song; Jinjing Chen; Richard M Peek; Lichen Yin; Lin-Feng Chen; Jianjun Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-13       Impact factor: 11.205

Review 4.  The first 1000 cultured species of the human gastrointestinal microbiota.

Authors:  Mirjana Rajilić-Stojanović; Willem M de Vos
Journal:  FEMS Microbiol Rev       Date:  2014-06-27       Impact factor: 16.408

5.  Functional disruption of peroxiredoxin by bismuth antiulcer drugs attenuates Helicobacter pylori survival.

Authors:  Yuen-Yan Chang; Tianfan Cheng; Xinming Yang; Lijian Jin; Hongzhe Sun; Hongyan Li
Journal:  J Biol Inorg Chem       Date:  2017-03-30       Impact factor: 3.358

Review 6.  What is the Relevance of Gastric Microbiota Beyond H. pylori?

Authors:  Kerstin Schütte; Peter Malfertheiner; Christian Schulz
Journal:  Curr Treat Options Gastroenterol       Date:  2019-12

Review 7.  From the stomach to other organs: Helicobacter pylori and the liver.

Authors:  Marek Waluga; Michał Kukla; Michał Żorniak; Agata Bacik; Rafał Kotulski
Journal:  World J Hepatol       Date:  2015-08-28

8.  Seven-day triple therapy is a better choice for Helicobacter pylori eradication in regions with low antibiotic resistance.

Authors:  Yue-Feng Tong; Jun Lv; Li-Yuan Ying; Fang Xu; Bo Qin; Ming-Tong Chen; Fei Meng; Miao-Ying Tu; Ning-Min Yang; You-Ming Li; Jian-Zhong Zhang
Journal:  World J Gastroenterol       Date:  2015-12-14       Impact factor: 5.742

9.  Comparison of concomitant therapy versus standard triple-drug therapy for eradication of Helicobacter pylori infection: A prospective open-label randomized controlled trial.

Authors:  Sanjeev Kumar Jha; Manish K Mishra; Kuldeep Saharawat; Praveen Jha; Shubham Purkayastha; Ravish Ranjan
Journal:  Indian J Gastroenterol       Date:  2019-09-14

10.  Impact of ethnicity in upper gastrointestinal hemorrhage.

Authors:  Casey S Wollenman; Rebecca Chason; Joan S Reisch; Don C Rockey
Journal:  J Clin Gastroenterol       Date:  2014-04       Impact factor: 3.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.